All Is Not Rite With This Company

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

While researching Walgreen (NYSE: WAG  ) as a possible outperform CAPScall, I couldn't help but notice that competitor Rite Aid (NYSE: RAD  ) makes a much more attractive underperform pick. This is a company that has not had a profitable quarter in half a decade. Debt is mounting, and the book value of assets is dwindling. Read on to see why I believe a Rite Aid recovery will be slow and painful -- if shareholders are lucky enough to have one at all.

What's right at Rite Aid
Fellow Fool Shubh Datta makes a compelling case to think Rite Aid might not be all bad. Notably, revenues in the fourth quarter jumped 11% over last year, helped by a 3% increase in same-store sales.

Much of the increase in sales was because of Rite Aid's pharmacy segment, which contributes 68% of sales. Not long ago, the Rite Aid in my own town had a giant banner out front, proclaiming, "Welcome Walgreen Customers!" referencing how Rite Aid had lucked out after a falling-out between Walgreen and pharmacy benefits manager Express Scripts (Nasdaq: ESRX  ) sent customers searching for a new pharmacy.

All those new customers have apparently also joined Rite Aid's Wellness+ customer loyalty program, giving them sale prices to incentivize them to shop more, and giving Rite Aid more access to precious customer spending data. The number of active members is up 16% over last year, an encouraging number for shareholders.

Health and beauty aids on a pig
Unfortunately, most of the 11% jump in sales in the fourth quarter came from the mercy of a calendar. The quarter had an extra week in it. Without that extra week, sales would only have increased 3%, a far less rosy comparison. Gross profit margin in the fourth quarter also fell 141 basis points, eroding the little good an increase in sales did.

Ironically, gross margin may have fallen in part because of the extra Wellness+ members. Change to Win Investment Group, or CtW, an investment group that works with pension funds sponsored by unions, including Rite Aid's own workers' union, recently issued an open letter calling on the company to disclose more details about the actual cost of Wellness+.

Based on company data, CtW found that sales per Wellness+ member have fallen more than 40% since the program's introduction, suggesting that the majority of the new members are the kind who sign up just to get a one-time deal. In fact, 46% of Wellness+ members have only used their card once or not at all in the past six months. What's worse, the program is intended in part to drive more customers to the pharmacy, the core of Rite Aid's business. But at a recent conference, management bluntly admitted that they "haven't driven a significant amount of additional foot traffic with [Wellness+] on the pharmacy side."

CtW isn't the only group sending Rite Aid angry letters. Two U.S. senators recently expressed concern over Rite Aid's "wellness ambassadors," essentially normal sales clerks dressed in white pharmacist coats. While the company insists the wellness ambassadors aren't giving out any inappropriate product advice or recommendations, this still seems like a worse marketing idea than the company's "With us, it's personal" slogan, which sounds more like the tag line to a revenge movie.

The Foolish bottom line
As Shubh points out, Rite Aid has suffered 19 consecutive quarters of losses. It has a precarious interest coverage ratio, and barely enough cash on the books to pay another quarter's worth of interest, forcing the company to barely scrape by.

Some have speculated that Rite Aid might at least be a buyout candidate, whether by top competitors Walgreen or CVS Caremark (NYSE: CVS  ) , or even Wal-Mart (NYSE: WMT  ) . I see this as unlikely. Wal-Mart has been more interested in emerging markets acquisitions lately, and with an enterprise value of $7.66 billion, most of which is debt, Rite Aid would significantly inflate its competitors' balance sheets -- the same mistake Rite Aid itself made several years ago. Rite Aid may be able to keep limping along, but I'm confident it will at least underperform the market for a while yet.

Don't let Rite Aid's troubles scare you off from the broader retail space, though. There are incredible opportunities out there, including The Motley Fool's Top Stock for 2012. You can uncover this soon-to-be-highflier that Wall Street is still aloof to in our special free report. Get your free copy now. Enjoy, and Fool on!

Fool contributor Jacob Roche holds no position in any of the companies mentioned. Check out his Motley Fool CAPS profile or follow his articles using Twitter or RSS. The Motley Fool owns shares of Wal-Mart Stores. Motley Fool newsletter services have recommended buying shares of Wal-Mart Stores and Express Scripts Holding. Motley Fool newsletter services have recommended creating a diagonal call position in Wal-Mart Stores. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (3) | Recommend This Article (9)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 26, 2012, at 4:23 PM, hughjwade wrote:

    Rite Aid is such an interesting case right now, because the case can be made that it continues to be doomed, or it is on the verge of becoming profitable. I'm still trying to figure out what the recent Jean Coutu sale of shares means. I mean, Rite Aid took that LIFO or FIFO charge, then Coutu sells a bunch of shares. Will the shareholders get screwed again, or are they somehow expecting to be profitable soon and making strategic counter moves at the right time.

  • Report this Comment On April 26, 2012, at 11:11 PM, Investor90210 wrote:

    In order to become profitable they need to be realistic about why they are not. The individuals responsible are only concerned about financially securing themselves, not the company. It is clear they could care less about that.

  • Report this Comment On June 11, 2012, at 7:30 PM, earleytech wrote:

    Well, I see they are finally replacing Mary Sammons after how many years. I want to know why it takes companies so long to replace CEO's who obviously aren't taking the company in a good direction? She has been there I think for over 10 years now! Sure the stock went up to $8 or so years back, but quickly went right back down. Time for a new bold fresh outlook if you ask me .. hopefully we will see something happening this summer after the switch, but I am not holding my breath. I will cross my fingers though.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1870572, ~/Articles/ArticleHandler.aspx, 10/27/2016 5:35:50 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 8 hours ago Sponsored by:
DOW 18,199.33 30.06 0.17%
S&P 500 2,139.43 -3.73 -0.17%
NASD 5,250.27 -33.13 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/26/2016 4:01 PM
RAD $6.79 Down -0.22 -3.14%
Rite Aid CAPS Rating: ****
CVS $87.57 Up +0.16 +0.18%
CVS Health CAPS Rating: ****
ESRX $70.39 Up +0.32 +0.46%
Express Scripts CAPS Rating: *****
WBA $82.30 Down -0.15 -0.18%
Walgreens Boots Al… CAPS Rating: ****
WMT $69.59 Up +0.23 +0.33%
Wal-Mart Stores CAPS Rating: ***